i-DEF Trial Keeps Hope Alive for Deferoxamine in Brain Bleeds i-DEF Trial Keeps Hope Alive for Deferoxamine in Brain Bleeds

The iron chelator was promising enough in a phase 2 futility design trial to have investigators looking ahead to further trials in intracranial hemorrhage.Medscape Medical News
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Cardiology News Source Type: news